Kawaguchi R

No ORCID on file · 16 papers in corpus · active 2006-2024

Study types

  • article 7
  • other 3
  • review 3

Condition tags

  • endometriosis 12
  • endometrioma 5
  • adenomyosis 1
other 2024
Microorganisms ·doi:10.3390/microorganisms12030538

Among epithelial ovarian cancer, clear cell carcinoma is common for chemo-resistance and high mortality. This cancer arises from benign ovarian endometrioma (OE), which is a high oxidative stress environment due to the cystic retention of m…

2024
Oncology letters ·doi:10.3892/ol.2024.14435

Tissue factor pathway inhibitor-2 (TFPI2) is a tumor marker for diagnosing ovarian cancer and ovarian clear cell carcinoma (OCCC); however, its effectiveness as a prognostic marker remains unclear. The present study aimed to investigate the…

other 2024
Diagnostics ·doi:10.3390/diagnostics14111069

BACKGROUND: Endometriosis-associated ovarian cancer (EAOC) is a well-known type of cancer that arises from ovarian endometrioma (OE). OE contains iron-rich fluid in its cysts due to repeated hemorrhages in the ovaries. However, distinguishi…

2024
Trials ·doi:10.1186/s13063-024-07923-2

BackgroundUterine leiomyomas are common for reproductive-aged women and affect women's quality of life due to heavy menstrual bleeding or dysmenorrhea. Leiomyomas grow according to estradiol exposure and decrease after post-menopause. In ca…

article 2022
Biomedicines ·doi:10.3390/biomedicines10112683

BACKGROUND: Magnetic resonance (MR) relaxometry provides a noninvasive tool to discriminate endometriosis-associated ovarian cancer (EAOC) from ovarian endometrioma (OE) with high accuracy. However, this method has a limitation in discrimin…

article 2019
Case reports in oncology ·doi:10.1159/000496178

BACKGROUND AND OBJECTIVE: Atypical endometriosis is reported to possess a precancerous potential attributed to premalignant changes characterized by cytological atypia and architecture proliferation. Although the coexistence of atypical end…

other 2019
Journal of ovarian research ·doi:10.1186/s13048-019-0497-1

BACKGROUND: Common cancerous histological types associated with endometriosis are clear cell carcinoma (CCC) and endometrioid carcinoma (EC). CCC is regarded as an aggressive, chemoresistant histological subtype. Magnetic resonance imaging …

article 2019
Scientific reports ·doi:10.1038/s41598-019-54096-z

We aimed to retrospectively analyze the risk factors of a continuous dienogest (DNG) therapy for serious unpredictable bleeding in patients with symptomatic adenomyosis. This is a retrospective study based on data extracted from medical rec…

2018
World journal of oncology ·doi:10.14740/wjon1106w

BackgroundThe aim of our study was to evaluate the utility of three-dimensional magnetic resonance imaging (3D-MRI) in gynecologic fields. We examined the relation between tumor volume measured with 3D-MRI and lymph node metastasis in patie…

article 2017
Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine ·doi:10.2463/mrms.mp.2016-0149

PURPOSE: Mural nodules and papillary projections can be seen in benign ovarian endometriosis (OE) and malignant transformation of OE (endometriosis-associated ovarian cancer [EAOC]), which can pose a challenging diagnostic dilemma to clinic…

review 2011
Oncology reports ·doi:10.3892/or.2011.1456

This review summarizes data from recent molecular genetic and epidemiology studies of the generic term 'female pelvic cancer'. The English-language literature was reviewed for genetic, epigenetic, epidemiologic and environmental risk factor…

review 2011
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1097/igc.0b013e318222cfdd

ObjectiveEpithelial ovarian cancer (EOC) is the most lethal pelvic gynecologic cancer. Clear cell carcinoma (CCC) and endometrioid adenocarcinoma (EAC) of the ovary have been associated with endometriosis, thus indicating that endometriosis…

review 2010
Human immunology ·doi:10.1016/j.humimm.2010.12.009

In the ovary, clear cell carcinoma (CCC) and endometrioid adenocarcinoma occur in the setting of endometriosis. In this review, we discuss the role of innate immune responses, specifically endogenous ligands (also known as "alarmins"), thei…

article 2008
Journal of Obstetrics and Gynaecology Research ·doi:10.1111/j.1447-0756.2008.00849.x

OBJECTIVE: The purpose of this study was to describe the clinicopathologic features of malignant transformation in patients with ovarian endometrioma, their treatment and outcome in the Kinki region, Japan. PATIENTS AND METHODS: Patients me…

article 2008
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2007.06.017

ObjectiveOur prospective studies in Japan have found an increased ovarian cancer incidence in women with ovarian endometrioma (standardized incidence ratio, 8.95; 95% confidence intervals, 4.12-5.3). The risk increased with increasing age a…

article 2006
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1111/j.1525-1438.2006.00625.x

The purpose of this study was to determine whether Akt and mammalian target of rapamycin (mTOR), downstream targets of phosphatidylinositol 3-kinase, are activated in endometriosis and ovarian cancer specimens. We measured total and phospho…